The group’s research focuses on understanding the molecular mechanisms that endow tumor cells with adaptive cellular plasticity in the context of acquired drug resistance. The goal is to determine new avenues of therapeutic intervention to improve our ability to treat aggressive cancers.
The group is part of the Center for Cancer Biomarkers, CCBIO at the Departments of Biomedicine and Clinical Research at the University of Bergen, and of the Cellular Networks research group at the Department of Biomedicine.
Principal Investigator
The group is headed by professor James Lorens (visit his personal page).